CompletedNCT00056472
Olanzapine and sertraline for depression with psychotic symptoms
About this title
Read the official source — NCT00056472Medication studyAges 18+United States + Canada
Understand this study
Who was this study for?
Listed age limits: from 18 years.
- Listed locations
- Worcester and 3 more locationsSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Study information
Study start dateJanuary 2003
- Recruitment status
- Completed
- Enrollment listed in the registry
- 259
- Sponsor
- Weill Medical College of Cornell University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug, Other
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- United States, Canada
- Age range
- Over 18 Years
- Official registry ID
- NCT00056472
- Official title
Show the full official title
Effectiveness of Selective Serotonin Reuptake Inhibitors Combined With Antipsychotic Medication for the Treatment of Psychotic Depression
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Worcester, United States · New York, United States · Pittsburgh, United States
1 more locations
- Toronto, Canada
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Weill Medical College of Cornell University, a university.
Did this study involve medication?
Yes. The study involved medication, including Olanzapine and Sertraline.
Who was this study for?
Listed age limits: from 18 years.
